SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about press release

05 Mar 2026 Evaluate
Granules India has enclosed a copy of Press Release titled ‘Granules India’s Packaging Facility in US gets FDA EIR with No Action Indicated Status’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

897.50 7.95 (0.89%)
13-Jul-2026 12:39 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1925.95
Dr. Reddys Labs. 1232.45
Cipla 1427.55
Zydus Lifesciences 1131.15
Lupin 2492.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: